Search General Info
Search Education
Search Partnering Companies
![BIO International Convention](/sites/default/files/2021-09/_BIO_CONV_Logo-White.png)
Brinter is a BioTech/MedTech startup from the US and Finland. With our patented 3D (bio)printing technology, we develop, license, and sell in-vivo applications to our partners and customers.
Our applications are Cartilaginous Bio-Implants for regenerative medicine, and Personalized Drug Printing, for precision medicine.
Our partners and customers are clinics, hospitals, research & academia, CMOs/CROs, bio, and pharmaceutical companies.
Our application development is in North Carolina at Wake Forest WFIRM. Business HQ in Santa Monica, California. Technology R&D is in Finland. Our 17 people are primarily bio-scientists and engineers.
We have $1M in 3D bioprinter hardware sales (2020-22) from our application customers. Other: ~$3M in grants and $1.5M seed round (04/2021). We are currently raising our Series A round ($7M-$15M).
Our strategic investors and EXIT opportunities are in MedTech and Pharma industry (GE HealthCare, J&J MedTech, Roche etc.).
Our applications are Cartilaginous Bio-Implants for regenerative medicine, and Personalized Drug Printing, for precision medicine.
Our partners and customers are clinics, hospitals, research & academia, CMOs/CROs, bio, and pharmaceutical companies.
Our application development is in North Carolina at Wake Forest WFIRM. Business HQ in Santa Monica, California. Technology R&D is in Finland. Our 17 people are primarily bio-scientists and engineers.
We have $1M in 3D bioprinter hardware sales (2020-22) from our application customers. Other: ~$3M in grants and $1.5M seed round (04/2021). We are currently raising our Series A round ($7M-$15M).
Our strategic investors and EXIT opportunities are in MedTech and Pharma industry (GE HealthCare, J&J MedTech, Roche etc.).
![](https://778c1607566f28c5e8fd-e6db6de54823ad7fd298e0f6ff75b72a.ssl.cf1.rackcdn.com/BIO_4121_EOISBJNL_361_BrinterInc-FileId-326067.png)
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2018
Main Therapeutic Focus:
Regenerative Medicine
Lead Product in Development:
Cartilaginous Bio-Implants
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker
![](https://www.conferenceharvester.com/uploads/harvester/photos/AOQRKQVE-Presenter-AlapaattikoskiT.jpg)
BIO DOUBLE HELIX SPONSORS
![Sanofi logo](/sites/default/files/2022-05/Sanofi_Color_jpg_Double%20Helix.jpg)
![Eli Lilly and Company](/sites/default/files/2019-09/Eli%20Lilly%20and%20Company.png)
![Amgen logo](/sites/default/files/2022-05/Amgen_Color_png_Double%20Helix.png)
![Genentech logo](/sites/default/files/2022-05/Genentech_Color_png_Double%20Helix.png)
![Merck_logo_2022](/sites/default/files/2022-10/Merck_Color_.png)
![Avantor](/sites/default/files/2021-06/Avantor-BIO-DH-578.png)
![GSK logo](/sites/default/files/2023-04/gsk_color_png.png)
BIO HELIX SPONSORS
![Johnson and Johnson](/sites/default/files/2021-06/Johnson-Johnson-BIO-DH-578.png)
![Takeda logo](/sites/default/files/2022-05/Takeda_Color_jpg_Premier.jpg)
![Travere logo](/sites/default/files/2022-05/Travere_Color_png_Helix%20large.png)
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2024 All Rights Reserved